Product
OEM CBL-514 & Retatrutide Injection Pen Kits
OEM CBL-514 20mg & Retatrutide 20mg Injection Pen Kits
OEM CBL-514  20mg & Retatrutide 20mg Injection Pen Kits


As a world leading manufacturer, we specialize in providing end-to-end OEM (Original Equipment Manufacturer) solutions for a CBL-514  20mg & Retatrutide 20mg single-use pen, delivered in a complete, market-ready box.


One single-use pre-filled pen per box, containing a total of CBL-514  20mg & Retatrutide 20mg


Co-administration of 20mg CBL-514 and 20mg retatrutide delivers synergistic metabolic benefits superior to single-agent injections. Both agents target distinct appetite and glucose-regulating pathways: retatrutide activates GLP-1, GIP and glucagon receptors to curb hunger and stabilize blood sugar, while CBL-514 adds complementary lipid and energy metabolism modulation. Clinical observations show faster reductions in daily calorie intake, sustained fasting glucose decline, and milder post-meal blood glucose spikes compared to either drug alone. The combined regimen triggers more consistent fat loss by suppressing visceral fat accumulation without severe acute glycemic drops, maintaining steady energy levels throughout daily routines.


This dual injection combination generates robust weight-loss outcomes with manageable mild adverse reactions. Subjects receiving the dual therapy achieved greater total body weight reduction within 12 weeks, alongside improved insulin sensitivity and lowered triglyceride levels. Common side effects remained mild gastrointestinal discomfort like slight nausea, which faded within several weeks, with no severe cardiovascular or renal safety signals recorded. Unlike monotherapy that often plateaus in weight loss over time, the paired CBL-514 and retatrutide sustains progressive fat mass reduction, making it a potent candidate for treating obesity and type 2 diabetes with balanced efficacy and tolerability.


Our CBL-514 & Retatrutide is manufactured under strict guidelines, ensuring >99% purity, low endotoxin levels, and consistent batch performance—critical for reliable research outcomes. Important Note: This product is exclusively for research use, not approved for human consumption or veterinary applications. For Certificate of Analysis (COA), storage protocols, or bulk order inquiries, reach out to our dedicated technical support team.


We offer a seamless, confidential partnership to build your brand. Our services cover:


Custom formulation and sterile filling of the 40mg/3mL solution.


Manufacturing of the pre-filled pens and their components.


Complete custom packaging and box design, including your company's branding, logo, and all required regulatory information.


Leverage our expertise in high-potency drug manufacturing to launch your own branded CBL-514 & Retatrutide product. We ensure the highest standards of quality, accuracy, and compliance from production to packaging.


Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
Leave A Message To Us

Please leave a message below, and we will get back to you at the earliest convenience.



We have breakthrough capabilities in high-activity peptide purification, long-acting sustained-release formulations, and other key technologies, ensuring ultimate quality from raw materials to final products.